Video

New superbug reaches the U.S.

CDC officials are working with health authorities to identify how the patient may have contracted the bacteria, including reviewing recent hospitalizations and other healthcare exposures


Researchers have found a person in the United States carrying bacteria resistant to antibiotics of last resort, according to an article on The Washington Post website.

Researchers worry that its colistin-resistance gene, known as mcr-1, could spread to other bacteria that can already evade other antibiotics.

Colistin is the antibiotic of last resort for particularly dangerous types of superbugs, including CRE, which health officials call a “nightmare bacteria.” 

CDC officials are working with health authorities to identify how the patient may have contracted the bacteria, including reviewing recent hospitalizations and other healthcare exposures.

Read the article.

 



June 7, 2016


Topic Area: Industry News


Recent Posts

Case Study: How NYU Langone Rebuilt for Resilience After Superstorm Sandy

Although the damage was severe, it provided a valuable opportunity for NYU Langone to assess structural vulnerabilities and increase facility resilience.


Frederick Health Hospital Faces 5 Lawsuits Following Ransomware Attack

The lawsuits accuse FHH of inadequate cybersecurity, poor breach notification and failing to protect patients from identity theft risks.


Arkansas Methodist Medical Center and Baptist Memorial Health Care to Merge

They have signed a non-binding letter of intent to complete a shared mission agreement to merge the two organizations.


Ground Broken on Intermountain Saratoga Springs Multi-Specialty Clinic

The clinic is scheduled to open and start seeing patients in the fall of 2026.


Electrical Fire Tests Resilience of Massachusetts Hospital

Signature Healthcare Brockton Hospital used opportunity to renovate key systems and components and expand facility operations.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.